About
Pims-e develops an inhalation technology offering a powder-based alternative to epinephrine auto-injectors for rapid treatment of life-threatening allergic reactions without the need for injection or refrigeration.
Explore Pims-e's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.